Press releases
- Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
- Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
- Twist Bioscience to Present at Upcoming Investor Conferences
- Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
- Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
- Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
More ▼
Key statistics
On Tuesday, Twist Bioscience Corp (0ME:FRA) closed at 44.10, -10.87% below its 52-week high of 49.48, set on Jun 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 44.83 |
---|---|
High | 44.83 |
Low | 44.10 |
Bid | -- |
Offer | -- |
Previous close | 44.10 |
Average volume | 100.80 |
---|---|
Shares outstanding | 58.23m |
Free float | 57.21m |
P/E (TTM) | -- |
Market cap | 2.76bn USD |
EPS (TTM) | -3.35 USD |
Data delayed at least 15 minutes, as of Jun 18 2024 14:29 BST.
More ▼